The Ohio State Board of Pharmacy has adopted major regulatory revisions to Ohio Administrative Code (OAC) 4729:5-2-01, filed in final form on July 14, 2026. Taking effect on February 1, 2027, the revised rule significantly reshapes the supervision, on-site presence, and qualification standards for individuals designated as the “Responsible Person” (RP) across all Terminal Distributor of Dangerous Drugs (TDDD) licenses.
For healthcare systems, community pharmacies, clinics, medical spas, EMS providers, and non-resident licensees operating in Ohio, this update replaces general oversight expectations with defined on-site hour minimums, documented quarterly site-visit alternatives, and new limits on serving as RP for multiple pharmacies. The Board strongly encourages licensees to use this implementation window to audit their operational structures and align staffing models before the rule takes effect.
What Is Ohio’s Responsible Person Framework?
Under Ohio law, every location licensed as a terminal distributor of dangerous drugs, including retail pharmacies, hospitals, clinics, medical spas, and EMS agencies, must have a designated Responsible Person (RP) on file with the Board at all times.
The RP is responsible for ensuring the terminal distributor’s requirements are met. This responsibility encompasses:
- The supervision and control of dangerous drugs and adequate safeguards, along with the security and control of dangerous drugs.
- Maintaining all required drug records.
- Ensuring the licensee complies with all federal and state laws, regulations, and rules governing the distribution of dangerous drugs.
The RP does not carry this responsibility alone. The rule also makes the terminal distributor itself, and all pharmacists or licensed health professionals on duty, responsible for compliance with state and federal drug distribution laws.
Core Administrative Rules: A terminal distributor must have an RP at all times. Any change in RP requires notifying the Board within 10 days of the effective date of the new RP’s appointment, through a Change of Responsible Person Request in eLicense Ohio (with a $15 processing fee). On the effective date of the change, the incoming RP must take a complete inventory of the controlled substances on hand, in accordance with 21 CFR 1304.11 and OAC 4729:5-3-07, and maintain that inventory record at the licensed location. According to the Board, this inventory requirement applies to any licensee permitted to order and possess controlled substances, even if no controlled substances are on-site. For a limited TDDD license, the change notification must also include a drug list.
Key Provisions of the Revised OAC 4729:5-2-01
The amended regulation transitions away from general oversight standards toward prescriptive, license-specific requirements.
1. In-State Outpatient Pharmacies: Hard Minimum Hours and Strict Dual-License Caps
For retail and community outpatient pharmacies, the RP must be an Ohio-licensed pharmacist and meet defined weekly operational hours:
- Operational 40+ hours per week: The RP must work on-site a minimum of 20 hours per week, except when absent due to authorized leave.
- Operational fewer than 40 hours per week: The RP must work on-site a minimum of 50% of the total hours the pharmacy is open weekly, except when absent due to authorized leave.
- Serving on Multiple Licenses: An RP generally may not serve more than one outpatient pharmacy. The rule allows an RP to serve up to two pharmacies only if:
- The pharmacist can meet the 20-hour / 50% weekly on-site requirements at the pharmacy or pharmacies served.
- Neither location has been disciplined for significant theft or loss of dangerous drugs within the preceding 12 months.
- Neither location has faced disciplinary action for minimum standards violations (OAC 4729:5-5-02 et seq.) within the preceding 12 months.
- Neither pharmacy is open more than 20 hours per day (in other words, 24-hour pharmacies do not qualify).
- The RP has been licensed to practice pharmacy in Ohio for at least one year.
- The RP is not currently on probation or otherwise restricted from serving as RP on multiple licenses by a Board settlement agreement or order.
2. Institutional Pharmacies: Quarterly Visit Option and Campus Limits
For institutional pharmacies (including institutional outpatient pharmacies, such as hospital outpatient pharmacies), the RP must also be an Ohio-licensed pharmacist. The rule introduces flexible pathways while regulating multi-facility supervision:
- On-Site Hours or Quarterly Visits: RPs must work 20 hours per week (if open 40+ hours), work 50% of the open hours (if open <40 hours), or conduct a documented quarterly on-site, in-person visit if the institutional pharmacy is owned and operated by the institutional facility and located on or directly adjacent to the institutional facility’s campus.
- Multi-Site Restriction: An RP can oversee up to two pharmacies, whether outpatient or institutional, only if both are located on a campus and the pharmacist is not on probation or otherwise restricted from serving on multiple licenses by a Board settlement agreement or order.
3. All Other TDDDs (Med Spas, Clinics, First-Aid, and OTPs)
For the wide range of non-pharmacy healthcare facilities, such as medical spas, primary care practices, addiction treatment centers, and specialty clinics, the rule provides three compliance options, and the RP must satisfy at least one:
- Monthly On-Site Work: The RP must work a minimum of 8 hours per month at the licensed facility; OR
- Quarterly On-Site Visits: The RP must conduct a documented in-person visit on a quarterly basis; OR
- Institutional Pharmacist Visits: If the terminal distributor is owned and operated by an institutional facility, the quarterly visit may be performed by a pharmacist employed by the facility, provided the visit documentation is delivered to the RP within 3 business days of the visit.
These options apply location by location. The rule sets no numerical cap on how many of these TDDDs one person may serve as RP, but the RP must meet the monthly-hour or quarterly-visit requirement at every licensed location.
4. Rigorous Requirements for Quarterly Site Visits
Where quarterly on-site visits are utilized in lieu of standing weekly or monthly hours, the visit cannot be a casual check-in. The visit must include a process to review and document compliance with:
- Drug security.
- Drug purchases and sales.
- Compounding compliance.
- Recordkeeping and temperature monitoring.
- Storage and disposal of adulterated or expired drugs.
- Any other requirements of R.C. Chapters 4729, 3719, and 3715 and the rules adopted under them.
The RP must document each visit (for institutional pharmacist visits, the visiting pharmacist documents it and sends the documentation to the RP). All visit documentation must be retained for 3 years from the date of the visit and kept at, or accessible by, the licensed location for immediate on-site inspection by a Board agent, officer, or inspector. The Board has published a sample site visit form.
Critical Compliance Traps
Ohio licensees and designated professionals must evaluate several practical exposure areas before February 2027:
- The 31-Day Absence Trigger: The hourly on-site requirements excuse absences due to authorized leave, which the rule defines as a scheduled vacation, illness, a federal or state holiday, or a temporary leave of absence lasting no more than 31 calendar days. The rule expressly provides that any RP absence exceeding 31 days requires the designation of a new RP for non-resident licensees, and the Board’s guidance applies the same rule to outpatient pharmacies, institutional pharmacies, and pain management clinics. Licensees should have a replacement RP ready to designate with the Board before any absence passes 31 days.
- Broad Disqualification Grounds: Under OAC 4729:5-2-01(I), unless otherwise approved by the Board, a terminal distributor may not have an RP who:
- Has been denied the right to work in a facility or serve as RP by an official order of the Board, or denied the right to work in such a facility by order of another professional licensing board or agency.
- Has committed a disqualifying offense, regardless of jurisdiction.
- Has been found eligible for intervention or treatment in lieu of conviction, or granted entry into a diversion or deferred prosecution program.
- Cannot practice according to acceptable and prevailing standards of care because of mental or physical illness.
- Is addicted to or abusing alcohol or drugs.
- Has been excluded from participation in Medicare or a state health care program.
- Has been denied a license or registration by the DEA or any state, or has been disciplined by the DEA or a state licensing agency where the action resulted in suspension, probation, surrender, or revocation, or was based on the inappropriate handling of controlled substances or other dangerous drugs.
Action Plan for Ohio Licensees
To achieve compliance ahead of the February 1, 2027 deadline, healthcare organizations and facility administrators should take immediate steps:
- Review Multi-Site RP Designations: Identify any pharmacists or physicians currently listed as RP on multiple registrations. For outpatient and institutional pharmacies, determine if these pairings remain permissible under the new caps or if separate RPs must be hired. For med spas, clinics, and other TDDDs, confirm the RP can meet the monthly-hour or quarterly-visit requirement at every location.
- Revise Employment Contracts and Hours: For outpatient pharmacies and clinics relying on hourly thresholds, audit shift schedules to confirm that RPs will routinely clear the 20-hour/week, 8-hour/week (pain management clinics), or 8-hour/month minimums.
- Standardize Inspection Workflows: For facilities adopting the quarterly site-visit protocol, deploy standardized written forms addressing the mandatory compliance categories, establish 3-year record retention workflows, and adopt the required written policy for correcting violations found during visits.
- Prepare Succession and Leave Protocols: Formalize written standard operating procedures for tracking RP leaves of absence approaching the 31-day ceiling to ensure replacement filings, 10-day Board notifications, and controlled substance inventories occur on time.
- Confirm RP Eligibility: Check each RP’s credentials against the Board’s RP qualifications resolution and screen each RP against the disqualification grounds, seeking Board approval in advance where needed.
Lengea Law advises med spas and aesthetic and wellness practices on terminal distributor licensing, responsible person designations, drug storage and recordkeeping, and state regulatory compliance. If you have questions about how the revised Ohio responsible person rule applies to your practice or locations, contact our team to schedule a consultation.
This article is intended for general informational purposes only and does not constitute legal advice. Because the rules governing terminal distributors of dangerous drugs vary by license type and continue to evolve, practices should consult qualified healthcare regulatory counsel regarding their specific operations.